ESSA Pharma Inc.
EPIX · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $268 | $136 | $80 | $308 |
| - Cash | $104 | $34 | $57 | $138 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $165 | $103 | $23 | $170 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$28 | -$26 | -$35 | -$37 |
| % Margin | – | – | – | – |
| Net Income | -$29 | -$27 | -$35 | -$37 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.64 | -0.6 | -0.8 | -0.96 |
| % Growth | -6.7% | 25% | 16.7% | – |
| Operating Cash Flow | -$23 | -$20 | -$29 | -$25 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$23 | -$20 | -$29 | -$25 |